A Glimmer of Hope in Alzheimer's Research A breakthrough in Alzheimer's disease research has sent shockwaves through the scientific community.
Researchers at King's College London have identified a promising new strategy by targeting multiple biological pathways simultaneously.
Their study, published in FEBS Open Bio, found that KCL 286, an experimental drug originally developed for spinal cord injury, reduced multiple hallmarks of Alzheimer's disease in mouse models.